Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive testing for Wilson's disease using tightly linked and flanking DNA markers.

L A Farrer1, A M Bowcock, J M Hebert

  • 1Department of Neurology, Boston University School of Medicine, MA 02118.

Neurology
|July 1, 1991
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.

The British journal of dermatology·2015
Same author

Inhibitory KIR3DL1 alleles are associated with psoriasis.

The British journal of dermatology·2015
Same author

Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseases.

Genes and immunity·2014
Same author

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

Oncogene·2014
Same author

CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.

Clinical pharmacology and therapeutics·2013
Same author

Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families.

The British journal of dermatology·2012

Researchers identified new DNA markers on chromosome 13, significantly improving genetic linkage testing for Wilson disease (WD). This allows for earlier prenatal and preclinical diagnosis, aiding timely intervention.

Area of Science:

  • Human Genetics
  • Molecular Biology
  • Medical Genetics

Background:

  • Wilson disease (WD) is a genetic disorder of copper metabolism.
  • Accurate genetic diagnosis is crucial for early intervention and preventing severe complications.
  • Previous genetic markers for WD had limitations in diagnostic accuracy and early detection.

Purpose of the Study:

  • To identify and characterize new DNA markers on chromosome 13 for Wilson disease.
  • To establish the chromosomal location of the Wilson disease gene (WND) using linkage analysis.
  • To evaluate the utility of these markers for prenatal and preclinical diagnosis of WD.

Main Methods:

  • Studied DNA polymorphisms in five new chromosome 13 markers across 52 Wilson disease families.
  • Performed multilocus linkage analysis using a genetic linkage map.

Related Experiment Videos

  • Applied genetic linkage testing for prenatal and preclinical diagnosis in affected families.

    • Main Results:

    • Significant evidence of linkage between the Wilson disease locus (WND) and all five new marker loci.
    • Multilocus analysis localized WND between markers D13S31 and D13S59 (0.4-1.2 cM distance).
    • Confirmed consistent chromosomal localization of the WD gene across diverse populations studied.

    Conclusions:

    • New polymorphic DNA markers on chromosome 13 facilitate accurate genetic linkage testing for Wilson disease.
    • Early prenatal and preclinical diagnosis of WD is achievable, enabling timely therapeutic intervention.
    • DNA testing offers a non-invasive alternative for diagnosis, especially with borderline clinical markers.